CAS 177036-94-1 Munditia >99.0% (HPLC) API Factory
Commercial Supple (CAS: 177036-94-1) Intermedia:
CAS: 177036-94-1
Methyl 2-Hydroxy-3-Methoxy-3,3-Diphenylpropanoate CAS: 178306-47-3
2-Hydroxy-3-Methoxy-3,3-Diphenylpropanoicum Acidum CAS: 178306-51-9
(S)-2-Hydroxy-3-Methoxy-3,3-Diphenylpropionicum Acidum CAS: 178306-52-0
L-Proline Methyl Ester hydrochlorid CAS: 2133-40-6
pyrimidine CAS: 35144-22-0
| Nomen chemicum | (S)-2-[(4,6-Dimethylpyrimidin-2-yl)oxy]-3-Methoxy-3,3-Diphenylpropionicum Acidum |
| Synonyma | (+-)-(2S)-2-((4,6-Dimethylpyrimidin-2-yl)oxy)-3-Methoxy-3,3-Diphenylpropanoicum Acidum |
| CAS Number | 177036-94-1 |
| Stock Status | In Stock, Productio Ascendite ad Tons |
| Formulae hypotheticae | C22H22N2O4 |
| M. Pondus | 378.43 |
| Imprimis gyrationis [α]D20 | +170.0° ad +176.0° (C=0.5, MeOH) |
| Liquescens punctum | 172.0~178.0℃(dec.) |
| Solubilitas | Solubile in Methanol;Solutum in Ethanol, Acetone;Insolubilis in aqua |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Aspectus | Alba vel Off-White pulveris |
| Lepidium sativum | HPLC;NMR;LC-MS |
| Substantiae cognatae | |
| Individual Impurity | ≤0.50% |
| Totalis immunditias | <1.00% |
| Damnum in Siccatio | ≤0.50% |
| Residere in Ignition | ≤0.20% |
| Metalla gravis | ≤20ppm |
| Puritas / Analysis Methodus | >99.0% (HPLC) |
| Test Standard | Enterprise Standard |
| Consuetudinem | Pharmaceutical intermedia |
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore
(CAS: 177036-94-1) APIest endothelin-A (ETA) receptor contrarius introductus ad tractationem oralem aegrorum cum hypertensione arteriali pulmonali (PAH), ad facultatem exercitii emendandi et moras clinicas augendas.PAH morbus rarus est arteriarum pulmonariarum, quae vascularium proliferation et retexere, inde in incremento progrediente in resistentia pulmonis vascularium et pressionis arteriarum pulmonalis, ac demum ventricularis dextri defectionis et praematura mors.Prima signa PAH includunt gradatim impetum suspirium, lassitudinem, palpitationem, hydropicum, et deficientem.Endothelin-1 (ET-1), vasoconstrictor potentis et mitogenis musculi lenis, est clavis contributor ad accelerationem morbi, eiusque effectus per activationem ofETA et ETB receptores mediantur.Mense Iunio MMVII, FDA approbationem concessit (CAS: 177036-94-1) API tractatio semel in cotidiana PAH.
